While less common than in early pandemic waves, some individuals still experience taste and smell loss with current COVID-19 variants.
The early days of the COVID-19 pandemic brought a striking and often unsettling symptom: the sudden disappearance of taste and smell. This unique sensory loss became a hallmark of the infection, prompting many to wonder about its mechanisms and duration. As the virus has mutated and evolved, so too has its presentation, leading to questions about whether this particular symptom remains a significant concern for those contracting COVID-19 today.
The Initial Impact of COVID-19 on Senses
When SARS-CoV-2 first emerged, anosmia (loss of smell) and dysgeusia (loss of taste) stood out as distinct indicators. Unlike typical cold viruses that might dull senses due to congestion, COVID-19 often caused a complete and sudden loss, even without nasal blockage.
The scientific understanding quickly pointed to the virus’s interaction with specific cells in the olfactory epithelium, the tissue lining the nasal cavity responsible for smell. The virus primarily targets sustentacular cells, which are vital for supporting olfactory sensory neurons, rather than directly infecting the neurons themselves. These sustentacular cells are rich in ACE2 receptors, the primary entry point for SARS-CoV-2.
- Olfactory Epithelium: The primary site of viral action, where support cells are infected.
- ACE2 Receptors: Abundant on sustentacular cells, facilitating viral entry.
- Inflammation: Viral infection triggers an inflammatory response that disrupts the function of nearby olfactory neurons, leading to sensory loss.
Shifting Trends with New Variants
As SARS-CoV-2 continued to mutate, new variants emerged, each with slightly different characteristics, including how they affected the human body. Early variants like Alpha and Delta were frequently associated with taste and smell loss. However, with the rise of the Omicron variant and its subsequent sub-lineages, a noticeable shift occurred in symptom profiles.
The Omicron variant, first identified in late 2021, demonstrated a greater propensity for upper respiratory tract infection and appeared to be less efficient at infecting lung tissue compared to earlier strains. This change in viral tropism, or the types of cells the virus prefers to infect, played a role in the altered symptom landscape. Research indicates that Omicron’s replication strategy might lead to less neuroinflammation or direct impact on the olfactory bulb compared to its predecessors. For current data on COVID-19 variants and their characteristics, you can refer to the CDC.
Omicron’s Distinctive Presentation
Studies consistently show that Omicron and its sub-variants (such as BA.1, BA.2, BA.4, BA.5, and XBB) cause taste and smell loss at a significantly lower rate than earlier variants. While it still occurs, it is no longer the prominent, almost guaranteed symptom it once was.
The reasons for this reduced incidence are multifaceted:
- Altered Cell Tropism: Omicron appears to have a reduced ability to infect cells deep within the olfactory epithelium that are critical for sustained sensory disruption.
- Immune Evasion: A population with higher rates of vaccination and prior infection means many individuals have some level of immune protection, which can lead to milder symptoms overall, including less severe sensory disruption.
- Faster Clearance: Some evidence suggests that Omicron may be cleared more quickly from the upper respiratory tract, potentially limiting the duration of inflammation that affects smell and taste.
Incidence Rates: What the Data Shows
Multiple observational studies and meta-analyses have tracked the prevalence of taste and smell loss across different COVID-19 waves. The trend is clear: a decline in reported cases of anosmia and dysgeusia as newer variants became dominant.
For example, early studies on the original SARS-CoV-2 strain and the Alpha variant reported taste and smell loss rates as high as 60-80% in symptomatic individuals. With the Delta variant, these rates saw a slight decrease but remained substantial. However, with Omicron, the reported incidence dropped considerably, often falling to 10-20% or even lower in some populations, particularly among vaccinated individuals. The World Health Organization (WHO) provides global updates on COVID-19 symptom prevalence, which can be found on their WHO website.
Factors Influencing Symptom Presentation
The likelihood and severity of taste and smell loss with COVID-19 are not uniform. Several factors play a role:
- Vaccination Status: Vaccinated individuals are less likely to experience taste and smell loss, and if they do, the duration is often shorter and the severity milder. Vaccines help the immune system mount a faster, more effective response, limiting viral replication and subsequent inflammation.
- Prior Infection: Individuals with previous COVID-19 infections may have some residual immunity that can modify symptom presentation upon re-infection, potentially reducing the risk of sensory loss.
- Variant Type: As discussed, newer variants like Omicron are inherently less prone to causing these specific symptoms.
- Age: Some research suggests that younger individuals might report taste and smell loss more frequently than older adults, though this can be influenced by reporting bias.
| Variant Group | Typical Incidence Range | Notes |
|---|---|---|
| Original/Alpha | 60-80% | High prevalence, often sudden and complete. |
| Delta | 40-60% | Still common, but slightly reduced from Alpha. |
| Omicron & Sub-variants | 10-20% | Significantly lower, less common as a primary symptom. |
Mechanisms Behind Persistent Sensory Loss
Even with lower incidence rates, some individuals still experience prolonged or persistent taste and smell dysfunction after a COVID-19 infection. This condition, often grouped under “Long COVID” or Post-Acute Sequelae of SARS-CoV-2 infection (PASC), can be quite disruptive to daily life.
The mechanisms behind persistent sensory loss are complex and still under investigation, but current understanding points to several possibilities:
- Sustained Inflammation: Chronic inflammation in the olfactory epithelium can prevent the proper regeneration and function of supporting cells and neurons.
- Damage to Olfactory Neurons: While the virus may not directly infect neurons, the severe inflammation can lead to indirect damage or apoptosis (programmed cell death) of olfactory sensory neurons.
- Disrupted Neurogenesis: The olfactory system has a remarkable ability to regenerate neurons. Persistent infection or inflammation can interfere with this regeneration process, leading to a prolonged deficit.
- Central Nervous System Involvement: While less common, some theories suggest that in certain cases, the virus or the inflammatory response could affect parts of the brain involved in processing smell and taste signals.
| Mechanism | Description |
|---|---|
| Chronic Inflammation | Ongoing immune response in nasal tissues. |
| Olfactory Neuron Damage | Indirect harm to sensory cells from inflammation. |
| Impaired Regeneration | Disruption of the body’s natural cell repair process. |
Recovery and Management of Sensory Dysfunction
For most people who experience taste and smell loss with COVID-19, recovery occurs naturally within a few weeks to months. However, for a subset of individuals, the dysfunction can persist for much longer, sometimes over a year.
One of the most widely recommended and evidence-backed interventions for persistent smell loss is olfactory training, often called “smell training.” This involves regularly sniffing a set of strong, distinct odors (like essential oils of rose, lemon, clove, and eucalyptus) to stimulate and retrain the olfactory system. It’s akin to physical therapy for the nose.
- Olfactory Training: A structured practice of smelling specific scents daily to aid recovery.
- Time: Patience is key, as nerve regeneration and retraining can take many months.
- Nutritional Support: Ensuring adequate intake of vitamins and minerals, particularly zinc and Vitamin A, which play roles in sensory health, might be beneficial, though direct evidence for their efficacy in COVID-related anosmia is limited.
- Medical Consultation: For persistent and severe cases, consulting with an otolaryngologist (ear, nose, and throat specialist) can provide guidance and rule out other causes.
Why Monitoring Sensory Symptoms Remains Important
Even with the reduced incidence, taste and smell loss with COVID-19 is not gone. It remains a symptom that can significantly affect an individual’s quality of life. The ability to smell and taste is crucial for enjoyment of food, appetite regulation, and even safety (detecting gas leaks, spoiled food, smoke).
Ongoing research continues to investigate the long-term effects of COVID-19 on sensory systems, including potential links to other neurological issues. Understanding the changing symptom profile of COVID-19 helps public health efforts, diagnostic accuracy, and the development of effective treatments for those affected.
References & Sources
Mo Maruf
I created WellFizz to bridge the gap between vague wellness advice and actionable solutions. My mission is simple: to decode the research and give you practical tools you can actually use.
Beyond the data, I am a passionate traveler. I believe that stepping away from the screen to explore new environments is essential for mental clarity and physical vitality.